Evidence map›Paper›PMID 33583245›Full record

ArticleThe Journal of international medical research2021

Acute-onset paraneoplastic cerebellar degeneration secondary to neuroendocrine carcinoma with atypical prognosis: a case report.

Kunyu Wang, Yan Miao, Haoyong Ning, Feng Guo, Yang Bian, Qingqing Wang, Chenjing Sun, Xiaokun Qi, Feng Qiu

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kunyu WangDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Yan MiaoDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Haoyong NingDepartment of Pathology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Feng GuoDepartment of Nuclear Medicine, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Yang BianDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-4002-5646
Qingqing WangDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Chenjing SunDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Xiaokun QiDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
Feng QiuDepartment of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0001-6931-1219
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a neurological syndrome that is likely caused by tumor-induced autoimmunity against the cerebellum. Neuroendocrine carcinoma (NEC) is a type of neoplasm with high-grade malignant histology and biological behavior. The prognosis for both PCD and NEC is typically poor. We report a case of PCD secondary to metastatic NEC in the lymph nodes, with an unknown primary origin. The case presented acute cerebellar manifestations with typical neuroimaging findings, but with atypical prognosis after lymph node dissection. Neurological symptoms can provide clues to potential tumors, and early antitumor treatment may have contributed to the positive prognosis of PCD secondary to NEC in the present case.

Indexed as

Carcinoma, NeuroendocrineParaneoplastic Cerebellar DegenerationCerebellumHumansLymph Node ExcisionPrognosisacute cerebellar manifestationmetastasisneuroendocrine carcinomaparaneoplastic cerebellar degenerationParaneoplastic neurological syndromestumor

Identifiers

PMID33583245
PMCPMC7890730
OpenAlexW3129622351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.